{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:09:49Z","timestamp":1776103789254,"version":"3.50.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"DOI":"10.1007\/s13760-026-03056-2","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:39:58Z","timestamp":1776094798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 2 diabetes mellitus in people with multiple sclerosis: a systematic review and meta-analysis"],"prefix":"10.1007","author":[{"given":"Omid","family":"Mirmosayyeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysa","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Vaheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Yazdan Panah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"1","key":"3056_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis\u2013a review. Eur J Neurol 26(1):27\u201340","journal-title":"Eur J Neurol"},{"issue":"13","key":"3056_CR2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","volume":"74","author":"R Marrie","year":"2010","unstructured":"Marrie R et al (2010) Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 74(13):1041\u20131047","journal-title":"Neurology"},{"issue":"1","key":"3056_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ane.13516","volume":"145","author":"G Maric","year":"2022","unstructured":"Maric G et al (2022) Impact of comorbidities on the disability progression in multiple sclerosis. Acta Neurol Scand 145(1):24\u201329","journal-title":"Acta Neurol Scand"},{"key":"3056_CR4","doi-asserted-by":"publisher","first-page":"104084","DOI":"10.1016\/j.msard.2022.104084","volume":"67","author":"M Staniki\u0107","year":"2022","unstructured":"Staniki\u0107 M et al (2022) Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry. Multiple Scler Relat Disorders 67:104084","journal-title":"Multiple Scler Relat Disorders"},{"issue":"1","key":"3056_CR5","first-page":"14","volume":"16","author":"E Cevenini","year":"2013","unstructured":"Cevenini E, Monti D, Franceschi C (2013) Inflamm-ageing. Curr Opin Clin Nutr Metabolic Care 16(1):14\u201320","journal-title":"Curr Opin Clin Nutr Metabolic Care"},{"issue":"9","key":"3056_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Reviews Cardiol 15(9):505\u2013522","journal-title":"Nat Reviews Cardiol"},{"issue":"16","key":"3056_CR7","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1212\/WNL.0000000000004508","volume":"89","author":"A Thormann","year":"2017","unstructured":"Thormann A et al (2017) Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality. Neurology 89(16):1668\u20131675","journal-title":"Neurology"},{"issue":"12","key":"3056_CR8","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1177\/1352458513504252","volume":"19","author":"I Wens","year":"2013","unstructured":"Wens I et al (2013) Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis\u2013a systematic review. Multiple Scler J 19(12):1556\u20131564","journal-title":"Multiple Scler J"},{"issue":"3","key":"3056_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1212\/WNL.0000000000001718","volume":"85","author":"RA Marrie","year":"2015","unstructured":"Marrie RA et al (2015) Effect of comorbidity on mortality in multiple sclerosis. Neurology 85(3):240\u2013247","journal-title":"Neurology"},{"key":"3056_CR10","doi-asserted-by":"crossref","unstructured":"Strati M et al (2024) Early onset type 2 diabetes mellitus: an update. Endocrine pp 1\u201314","DOI":"10.1007\/s12020-024-03772-w"},{"key":"3056_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.msard.2018.10.018","volume":"27","author":"RA Marrie","year":"2019","unstructured":"Marrie RA et al (2019) Diabetes and anxiety adversely affect cognition in multiple sclerosis. Multiple Scler Relat disorders 27:164\u2013170","journal-title":"Multiple Scler Relat disorders"},{"key":"3056_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.msard.2019.01.045","volume":"30","author":"FB Briggs","year":"2019","unstructured":"Briggs FB, Thompson NR, Conway DS (2019) Prognostic factors of disability in relapsing remitting multiple sclerosis. Multiple Scler Relat disorders 30:9\u201316","journal-title":"Multiple Scler Relat disorders"},{"issue":"15","key":"3056_CR13","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.3390\/jcm12154948","volume":"12","author":"V Giannopapas","year":"2023","unstructured":"Giannopapas V et al (2023) The prevalence of diabetes mellitus type II (DMII) in the multiple sclerosis population: a systematic review and meta-analysis. J Clin Med 12(15):4948","journal-title":"J Clin Med"},{"key":"3056_CR14","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s10072-017-3080-9","volume":"38","author":"M Abbasi","year":"2017","unstructured":"Abbasi M et al (2017) Multiple sclerosis and environmental risk factors: a case-control study in Iran. Neurol Sci 38:1941\u20131951","journal-title":"Neurol Sci"},{"key":"3056_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.msard.2018.10.011","volume":"27","author":"L Lorefice","year":"2019","unstructured":"Lorefice L et al (2019) Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case-control MRI study. Multiple Scler Relat disorders 27:74\u201378","journal-title":"Multiple Scler Relat disorders"},{"issue":"3","key":"3056_CR16","doi-asserted-by":"publisher","first-page":"e0300708","DOI":"10.1371\/journal.pone.0300708","volume":"19","author":"AJ Brnabic","year":"2024","unstructured":"Brnabic AJ et al (2024) Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework. PLoS ONE 19(3):e0300708","journal-title":"PLoS ONE"},{"key":"3056_CR17","doi-asserted-by":"publisher","first-page":"105613","DOI":"10.1016\/j.msard.2024.105613","volume":"86","author":"R Hadidchi","year":"2024","unstructured":"Hadidchi R et al (2024) SARS-CoV-2 infection increases long-term multiple sclerosis disease activity and all-cause mortality in an underserved inner-city population. Multiple Scler Relat Disorders 86:105613","journal-title":"Multiple Scler Relat Disorders"},{"key":"3056_CR18","doi-asserted-by":"crossref","unstructured":"Jacobsen JR et al (2024) Association of Multiple Sclerosis with incident Diabetes: A nationwide cohort study. Diabetes & Metabolism, p 101551","DOI":"10.1016\/j.diabet.2024.101551"},{"key":"3056_CR19","doi-asserted-by":"publisher","first-page":"105519","DOI":"10.1016\/j.msard.2024.105519","volume":"85","author":"EB Cho","year":"2024","unstructured":"Cho EB et al (2024) The risk of type 2 diabetes mellitus in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study. Multiple Scler Relat Disorders 85:105519","journal-title":"Multiple Scler Relat Disorders"},{"issue":"6","key":"3056_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/13524585231164296","volume":"29","author":"R Palladino","year":"2023","unstructured":"Palladino R et al (2023) Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based study. Multiple Scler J 29(6):671\u2013679","journal-title":"Multiple Scler J"},{"key":"3056_CR21","doi-asserted-by":"publisher","first-page":"1214652","DOI":"10.3389\/fnins.2023.1214652","volume":"17","author":"EB Cho","year":"2023","unstructured":"Cho EB et al (2023) The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder. Front NeuroSci 17:1214652","journal-title":"Front NeuroSci"},{"issue":"5","key":"3056_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00198-023-06715-9","volume":"34","author":"SY Jung","year":"2023","unstructured":"Jung SY et al (2023) Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea. Osteoporos Int 34(5):925\u2013933","journal-title":"Osteoporos Int"},{"issue":"12","key":"3056_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrendo.2013.131","volume":"9","author":"LA Velloso","year":"2013","unstructured":"Velloso LA, Eizirik DL, Cnop M (2013) Type 2 diabetes mellitus\u2014an autoimmune disease? Nat Reviews Endocrinol 9(12):750\u2013755","journal-title":"Nat Reviews Endocrinol"},{"issue":"5","key":"3056_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.je.2016.06.006","volume":"27","author":"W-H Hou","year":"2017","unstructured":"Hou W-H et al (2017) A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus. J Epidemiol 27(5):235\u2013241","journal-title":"J Epidemiol"},{"key":"3056_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.msard.2018.07.011","volume":"25","author":"P Saroufim","year":"2018","unstructured":"Saroufim P et al (2018) Cardiovascular conditions in persons with multiple sclerosis, neuromyelitis optica and transverse myelitis. Multiple Scler Relat disorders 25:21\u201325","journal-title":"Multiple Scler Relat disorders"},{"key":"3056_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-021-01671-z","volume":"10","author":"R Sarkis-Onofre","year":"2021","unstructured":"Sarkis-Onofre R et al (2021) How to properly use the PRISMA Statement. Syst Reviews 10:1\u20133","journal-title":"Syst Reviews"},{"issue":"Pt 1","key":"3056_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.envint.2018.07.015","volume":"121","author":"RL Morgan","year":"2018","unstructured":"Morgan RL et al (2018) Identifying the PECO: a framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. Environ Int 121(Pt 1):1027","journal-title":"Environ Int"},{"key":"3056_CR28","unstructured":"Wells GA et al (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"issue":"7568","key":"3056_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","volume":"333","author":"J Lau","year":"2006","unstructured":"Lau J et al (2006) The case of the misleading funnel plot. BMJ 333(7568):597\u2013600","journal-title":"BMJ"},{"issue":"8","key":"3056_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D","volume":"17","author":"RJ Hardy","year":"1998","unstructured":"Hardy RJ, Thompson SG (1998) Detecting and describing heterogeneity in meta-analysis. Stat Med 17(8):841\u2013856","journal-title":"Stat Med"},{"issue":"7109","key":"3056_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"key":"3056_CR32","doi-asserted-by":"crossref","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088\u20131101","DOI":"10.2307\/2533446"},{"key":"3056_CR33","unstructured":"Team RC (2020) RA language and environment for statistical computing, R Foundation for Statistical. Computing"},{"issue":"6","key":"3056_CR34","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D et al (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res 27(6):1785\u20131805","journal-title":"Stat Methods Med Res"},{"key":"3056_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X et al (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:1\u201313","journal-title":"BMC Med Res Methodol"},{"key":"3056_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jocn.2023.04.005","volume":"112","author":"V Giannopapas","year":"2023","unstructured":"Giannopapas V et al (2023) Do cardiovascular disease comorbidities affect the cognitive function of Multiple Sclerosis patients? J Clin Neurosci 112:20\u201324","journal-title":"J Clin Neurosci"},{"key":"3056_CR37","doi-asserted-by":"publisher","first-page":"104370","DOI":"10.1016\/j.msard.2022.104370","volume":"69","author":"AS Silva","year":"2023","unstructured":"Silva AS et al (2023) Metabolic syndrome parameters and multiple sclerosis disease outcomes: A Portuguese cross-sectional study. Multiple Scler Relat Disorders 69:104370","journal-title":"Multiple Scler Relat Disorders"},{"issue":"1","key":"3056_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000527673","volume":"86","author":"P Arroyo-Pereiro","year":"2023","unstructured":"Arroyo-Pereiro P et al (2023) Influence of Cardiovascular Risk Factors in Early Relapsing-Remitting Multiple Sclerosis: A Retrospective Analysis. Eur Neurol 86(1):73\u201377","journal-title":"Eur Neurol"},{"issue":"suppl 4","key":"3056_CR39","first-page":"475","volume":"33","author":"M Bo\u0161njak Pa\u0161i\u0107","year":"2021","unstructured":"Bo\u0161njak Pa\u0161i\u0107 M et al (2021) Comorbidities in Patients with Multiple Sclerosis in Croatia. Psychiatria Danubina 33(suppl 4):475\u2013479","journal-title":"Psychiatria Danubina"},{"key":"3056_CR40","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s10072-020-04727-5","volume":"42","author":"GD Maric","year":"2021","unstructured":"Maric GD et al (2021) The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data. Neurol Sci 42:1887\u20131893","journal-title":"Neurol Sci"},{"key":"3056_CR41","doi-asserted-by":"publisher","first-page":"102565","DOI":"10.1016\/j.msard.2020.102565","volume":"46","author":"E Ciampi","year":"2020","unstructured":"Ciampi E et al (2020) Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes. Multiple Scler Relat Disorders 46:102565","journal-title":"Multiple Scler Relat Disorders"},{"key":"3056_CR42","doi-asserted-by":"publisher","first-page":"101904","DOI":"10.1016\/j.msard.2019.101904","volume":"39","author":"MB D\u2019hooghe","year":"2020","unstructured":"D\u2019hooghe MB et al (2020) Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis. Multiple Scler Relat Disorders 39:101904","journal-title":"Multiple Scler Relat Disorders"},{"key":"3056_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-017-0914-2","volume":"17","author":"A Sicras-Mainar","year":"2017","unstructured":"Sicras-Mainar A et al (2017) Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain. BMC Neurol 17:1\u20136","journal-title":"BMC Neurol"},{"issue":"6","key":"3056_CR44","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3174\/ajnr.A4681","volume":"37","author":"R Zivadinov","year":"2016","unstructured":"Zivadinov R et al (2016) Autoimmune comorbidities are associated with brain injury in multiple sclerosis. Am J Neuroradiol 37(6):1010\u20131016","journal-title":"Am J Neuroradiol"},{"issue":"8","key":"3056_CR45","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/ene.12720","volume":"22","author":"M Moccia","year":"2015","unstructured":"Moccia M et al (2015) The Framingham cardiovascular risk score in multiple sclerosis. Eur J Neurol 22(8):1176\u20131183","journal-title":"Eur J Neurol"},{"issue":"5","key":"3056_CR46","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2340\/16501977-0335","volume":"41","author":"AJ Dallmeijer","year":"2009","unstructured":"Dallmeijer AJ et al (2009) Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis. J Rehabil Med 41(5):322\u2013326","journal-title":"J Rehabil Med"},{"key":"3056_CR47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.msard.2017.10.019","volume":"19","author":"A Murtonen","year":"2018","unstructured":"Murtonen A et al (2018) Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections. Mult Scler Relat Disord 19:109\u2013114","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"3056_CR48","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.apmr.2021.05.012","volume":"102","author":"ES Gromisch","year":"2021","unstructured":"Gromisch ES, Neto LO, Turner AP (2021) What biopsychosocial factors explain self-management behaviors in multiple sclerosis? The role of demographics, cognition, personality, and psychosocial and physical functioning. Arch Phys Med Rehabil 102(10):1982\u20131988 e4","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"3056_CR49","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1212\/WNL.0000000000010024","volume":"95","author":"A Salter","year":"2020","unstructured":"Salter A et al (2020) Comorbidity is associated with disease activity in MS: findings from the CombiRx trial. Neurology 95(5):e446\u2013e456","journal-title":"Neurology"},{"key":"3056_CR50","doi-asserted-by":"publisher","first-page":"102593","DOI":"10.1016\/j.msard.2020.102593","volume":"46","author":"JR Abbatemarco","year":"2020","unstructured":"Abbatemarco JR et al (2020) Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patients. Multiple Scler Relat Disorders 46:102593","journal-title":"Multiple Scler Relat Disorders"},{"key":"3056_CR51","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s11011-019-00456-7","volume":"34","author":"T Flauzino","year":"2019","unstructured":"Flauzino T et al (2019) Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative\/nitrosative stress biomarkers: results of multivariate and machine learning procedures. Metab Brain Dis 34:1401\u20131413","journal-title":"Metab Brain Dis"},{"issue":"11","key":"3056_CR52","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3174\/ajnr.A5819","volume":"39","author":"D Rogers","year":"2018","unstructured":"Rogers D, Shah L, Wiggins R (2018) The central vein: FLAIR signal abnormalities associated with developmental venous anomalies in patients with multiple sclerosis. Am J Neuroradiol 39(11):2007\u20132013","journal-title":"Am J Neuroradiol"},{"issue":"24","key":"3056_CR53","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","volume":"89","author":"K Kowalec","year":"2017","unstructured":"Kowalec K et al (2017) Comorbidity increases the risk of relapse in multiple sclerosis: a prospective study. Neurology 89(24):2455\u20132461","journal-title":"Neurology"},{"issue":"2","key":"3056_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/1352458516650512","volume":"23","author":"DS Conway","year":"2017","unstructured":"Conway DS, Thompson NR, Cohen JA (2017) Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course. Multiple Scler J 23(2):277\u2013285","journal-title":"Multiple Scler J"},{"issue":"5","key":"3056_CR55","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.msard.2015.07.014","volume":"4","author":"K Fiest","year":"2015","unstructured":"Fiest K et al (2015) Comorbidity is associated with pain-related activity limitations in multiple sclerosis. Multiple Scler Relat disorders 4(5):470\u2013476","journal-title":"Multiple Scler Relat disorders"},{"issue":"10","key":"3056_CR56","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/0895-4356(94)90099-X","volume":"47","author":"ST Fleming","year":"1994","unstructured":"Fleming ST, BLake RL Jr (1994) Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol 47(10):1127\u20131132","journal-title":"J Clin Epidemiol"},{"key":"3056_CR57","doi-asserted-by":"crossref","unstructured":"Biswal NR et al (2023) An Observational Study of Multi-Faceted Demyelinating Disorders. Cureus 15(8)","DOI":"10.7759\/cureus.43775"},{"issue":"12","key":"3056_CR58","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1177\/13524585221096964","volume":"28","author":"EB Cho","year":"2022","unstructured":"Cho EB et al (2022) Acute myocardial infarction risk in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea. Multiple Scler J 28(12):1849\u20131858","journal-title":"Multiple Scler J"},{"issue":"11","key":"3056_CR59","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1136\/jnnp-2022-329628","volume":"93","author":"EB Cho","year":"2022","unstructured":"Cho EB et al (2022) Risk of stroke in multiple sclerosis and neuromyelitis optic spectrum disorder: a Nationwide cohort study in South Korea. J Neurol Neurosurg Psychiatry 93(11):1146\u20131153","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3056_CR60","doi-asserted-by":"publisher","first-page":"103488","DOI":"10.1016\/j.msard.2022.103488","volume":"58","author":"M Etemadifar","year":"2022","unstructured":"Etemadifar M et al (2022) Atherosclerosis and multiple sclerosis: An overview on the prevalence of risk factors. Multiple Scler Relat Disorders 58:103488","journal-title":"Multiple Scler Relat Disorders"},{"key":"3056_CR61","doi-asserted-by":"publisher","first-page":"102425","DOI":"10.1016\/j.msard.2020.102425","volume":"45","author":"C-W Fang","year":"2020","unstructured":"Fang C-W et al (2020) Epidemiology and comorbidities of adult multiple sclerosis and neuromyelitis optica in Taiwan, 2001\u20132015. Multiple Scler Relat Disorders 45:102425","journal-title":"Multiple Scler Relat Disorders"},{"issue":"9","key":"3056_CR62","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/ene.12738","volume":"22","author":"O Pinhas-Hamiel","year":"2015","unstructured":"Pinhas-Hamiel O et al (2015) Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability. Eur J Neurol 22(9):1275\u20131279","journal-title":"Eur J Neurol"},{"issue":"1","key":"3056_CR63","first-page":"847670","volume":"2013","author":"Y Warabi","year":"2013","unstructured":"Warabi Y et al (2013) Abnormal nerve conduction study findings indicating the existence of peripheral neuropathy in multiple sclerosis and neuromyelitis optica. Biomed Res Int 2013(1):847670","journal-title":"Biomed Res Int"},{"issue":"9","key":"3056_CR64","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/j.1468-1331.2010.02971.x","volume":"17","author":"JH Kang","year":"2010","unstructured":"Kang JH, Chen YH, Lin HC (2010) Comorbidities amongst patients with multiple sclerosis: a population-based controlled study. Eur J Neurol 17(9):1215\u20131219","journal-title":"Eur J Neurol"},{"key":"3056_CR65","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00415-020-10194-x","volume":"268","author":"LMP Lo","year":"2021","unstructured":"Lo LMP et al (2021) Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis. J Neurol 268:602\u2013612","journal-title":"J Neurol"},{"issue":"12","key":"3056_CR66","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1177\/1352458519872644","volume":"26","author":"J Chen","year":"2020","unstructured":"Chen J et al (2020) Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis. Multiple Scler J 26(12):1550\u20131559","journal-title":"Multiple Scler J"},{"issue":"2","key":"3056_CR67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000442203","volume":"46","author":"P Tettey","year":"2016","unstructured":"Tettey P et al (2016) Frequency of comorbidities and their association with clinical disability and relapse in multiple sclerosis. Neuroepidemiology 46(2):106\u2013113","journal-title":"Neuroepidemiology"},{"key":"3056_CR68","doi-asserted-by":"publisher","first-page":"102336","DOI":"10.1016\/j.msard.2020.102336","volume":"44","author":"RM Fahmi","year":"2020","unstructured":"Fahmi RM et al (2020) Metabolic syndrome components and disease disability in egyptian multiple sclerosis patients. Multiple Scler Relat disorders 44:102336","journal-title":"Multiple Scler Relat disorders"},{"key":"3056_CR69","doi-asserted-by":"publisher","first-page":"1275167","DOI":"10.3389\/fpubh.2024.1275167","volume":"12","author":"PVL Moreira","year":"2024","unstructured":"Moreira PVL et al (2024) Predicting the prevalence of type 2 diabetes in Brazil: a modeling study. Front Public Health 12:1275167","journal-title":"Front Public Health"},{"key":"3056_CR70","doi-asserted-by":"crossref","unstructured":"Bullard KM (2018) Prevalence of diagnosed diabetes in adults by diabetes type\u2014United States, 2016. MMWR. Morbidity and mortality weekly report p 67","DOI":"10.15585\/mmwr.mm6712a2"},{"issue":"10","key":"3056_CR71","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1139\/apnm-2018-0567","volume":"44","author":"Z Hosseini","year":"2019","unstructured":"Hosseini Z, Whiting SJ, Vatanparast H (2019) Type 2 diabetes prevalence among Canadian adults\u2014dietary habits and sociodemographic risk factors. Appl Physiol Nutr Metab 44(10):1099\u20131104","journal-title":"Appl Physiol Nutr Metab"},{"issue":"14","key":"3056_CR72","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1212\/WNL.0000000000002481","volume":"86","author":"RA Marrie","year":"2016","unstructured":"Marrie RA et al (2016) Sex differences in comorbidity at diagnosis of multiple sclerosis: a population-based study. Neurology 86(14):1279\u20131286","journal-title":"Neurology"},{"issue":"9855","key":"3056_CR73","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(12)61422-6","volume":"380","author":"RK Simmons","year":"2012","unstructured":"Simmons RK et al (2012) Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 380(9855):1741\u20131748","journal-title":"Lancet"},{"issue":"11","key":"3056_CR74","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/jpm13111524","volume":"13","author":"V Nociti","year":"2023","unstructured":"Nociti V, Romozzi M (2023) The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review. J Personalized Med 13(11):1524","journal-title":"J Personalized Med"},{"issue":"1","key":"3056_CR75","doi-asserted-by":"publisher","first-page":"e0263139","DOI":"10.1371\/journal.pone.0263139","volume":"17","author":"S Akhtar","year":"2022","unstructured":"Akhtar S et al (2022) Prevalence of type-2 diabetes and prediabetes in Malaysia: A systematic review and meta-analysis. PLoS ONE 17(1):e0263139","journal-title":"PLoS ONE"},{"issue":"5","key":"3056_CR76","doi-asserted-by":"publisher","first-page":"e015424","DOI":"10.1136\/bmjopen-2016-015424","volume":"7","author":"D Adeloye","year":"2017","unstructured":"Adeloye D et al (2017) Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis. BMJ open 7(5):e015424","journal-title":"BMJ open"},{"issue":"1\u20132","key":"3056_CR77","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jns.2014.10.020","volume":"347","author":"P Tettey","year":"2014","unstructured":"Tettey P et al (2014) Vascular comorbidities in the onset and progression of multiple sclerosis. J Neurol Sci 347(1\u20132):23\u201333","journal-title":"J Neurol Sci"},{"issue":"8","key":"3056_CR78","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.2337\/dc06-0811","volume":"29","author":"WI Hussein","year":"2006","unstructured":"Hussein WI, Reddy SS (2006) Prevalence of diabetes in patients with multiple sclerosis. Diabetes Care 29(8):1984","journal-title":"Diabetes Care"},{"key":"3056_CR79","doi-asserted-by":"publisher","first-page":"101987","DOI":"10.1016\/j.msard.2020.101987","volume":"40","author":"RA Marrie","year":"2020","unstructured":"Marrie RA, Kosowan L, Singer A (2020) Management of diabetes and hypertension in people with multiple sclerosis. Multiple Scler Relat disorders 40:101987","journal-title":"Multiple Scler Relat disorders"},{"key":"3056_CR80","doi-asserted-by":"publisher","first-page":"103135","DOI":"10.1016\/j.msard.2021.103135","volume":"54","author":"K Senzaki","year":"2021","unstructured":"Senzaki K et al (2021) Vascular endothelial dysfunction associated with severity in multiple sclerosis. Multiple Scler Relat Disorders 54:103135","journal-title":"Multiple Scler Relat Disorders"},{"issue":"12","key":"3056_CR81","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1177\/1352458511414041","volume":"17","author":"RA Marrie","year":"2011","unstructured":"Marrie RA, Cutter G, Tyry T (2011) Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis. Multiple Scler J 17(12):1464\u20131471","journal-title":"Multiple Scler J"},{"key":"3056_CR82","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11910-012-0293-4","volume":"12","author":"S Overs","year":"2012","unstructured":"Overs S et al (2012) Modifiable comorbidities and disability in multiple sclerosis. Curr Neurol Neurosci Rep 12:610\u2013617","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"9","key":"3056_CR83","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1080\/01616412.2019.1622873","volume":"41","author":"E Dardiotis","year":"2019","unstructured":"Dardiotis E et al (2019) Body mass index in patients with Multiple Sclerosis: a meta-analysis. Neurol Res 41(9):836\u2013846","journal-title":"Neurol Res"},{"issue":"7","key":"3056_CR84","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1468-1331.2008.02146.x","volume":"15","author":"J Perumal","year":"2008","unstructured":"Perumal J et al (2008) Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis. Eur J Neurol 15(7):677\u2013680","journal-title":"Eur J Neurol"},{"issue":"3","key":"3056_CR85","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jrsm.1547","volume":"13","author":"CB Migliavaca","year":"2022","unstructured":"Migliavaca CB et al (2022) Meta-analysis of prevalence: I 2 statistic and how to deal with heterogeneity. Res synthesis methods 13(3):363\u2013367","journal-title":"Res synthesis methods"},{"issue":"1","key":"3056_CR86","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/0004563216646397","volume":"54","author":"A Aregbesola","year":"2017","unstructured":"Aregbesola A et al (2017) Gender difference in type 2 diabetes and the role of body iron stores. Ann Clin Biochem 54(1):113\u2013120","journal-title":"Ann Clin Biochem"},{"key":"3056_CR87","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3389\/fneur.2020.00616","volume":"11","author":"F Gilli","year":"2020","unstructured":"Gilli F, DiSano KD, Pachner AR (2020) SeXX matters in multiple sclerosis. Front Neurol 11:616","journal-title":"Front Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03056-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03056-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03056-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:02:08Z","timestamp":1776099728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-026-03056-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":87,"alternative-id":["3056"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03056-2","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work the authors used Chat-GPT in order to improve the readability and language of the manuscript. After using this service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations of generative AI and AI-assisted technologies in the writing process"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}